PCF Pharma Compliance Congress Alumni Reflect on the Value of the Congress
  • Sponsored by the Pharmaceutical Compliance Forum
  • November 6 - 8, 2019
  • Onsite at the Mandarin Oriental, Washington, DC
  • Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
  • Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
  • www.PharmaCongress.com

Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com
- SAVE UP TO $200 -
Register by Friday, October 11, 2019
and save up to $200.
Click here to register.

Click here to view the agenda.
Click here to view the brochure.

"I have been associated with the Pharma Congress since its inception. It has and continues to represent the best practice for a conference for content quality and customer engagement. It has also become an annual reunion for compliance professionals where we can share experiences and challenges from the past year over coffee or cocktails."

Arjun Rajaratnam, JD, MS, Chief Compliance Officer, Smith & Nephew, Former Member, PCF Executive Committee

"I find the conference to provide a great litmus test, both from a leading and lagging perspective. I leave sessions confident that we are doing great in some areas and inspired to do better in others as we look to continually evolve our compliance programs. No matter what, I leave the conference with renewed energy and bring the learnings back to my organization."

Jonathan Glazier, MBA, JD, Head of Legal Compliance, Philips North America

"Pharma Congress and PCF have been a tremendous source of information and networking across the industry to bring "The Outside In". So much of what we do as Compliance Officers is understanding what our teams and companies want to accomplish for patients and balance that with the external factors and considerations that are so important to maintain trust and integrity. PCF allows the opportunity to learn in a safe and informative way and bring back to my partners that understanding and benchmarking. The Congress has allowed me to learn and grow as a Business Leader now in Compliance. Learning is critical for all of us in this profession and I am grateful to the Congress and PCF for providing that forum and support!"

Ann-Marie Tejcek, Senior Director, Ethics & Compliance North America, Lilly USA

"I always look forward to the November meeting - it's a great chance to hear the latest in enforcement areas, take home some best practices and new approaches and network with top compliance professionals."

Christie Camelio, Vice President, Deputy Global Chief Compliance Officer, Celgene

"For twenty years the Pharma Congress has been the 'Who's who' of companies, professionals, regulators, and thought leaders in the compliance space' and every year it gets better. There is no other forum with a greater concentration of experienced pharma and healthcare compliance professionals than the Pharma Congress and the networking alone is worth it. The meeting agenda is always top notch and the learning and networking continues through the breaks, the evening events, and well beyond the Congress."

Joe Zimmerman, Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals, PCF Co-chair

"The variety and level of topics covered at the Congress allow those starting in a compliance role or those who are attending for the twentieth time to learn and develop. As the newest PCF Co-Chair, I have been involved with the Congress at a different level. I have been amazed at the amount of careful planning that the PCF and Congress teams put into this event so that those in attendance can gain in the way that I have in previous years."

Donna White, CCEP, Vice President, Contracts & Compliance, Chiesi, USA, PCF Co-Chair

"I had the good fortune to be part of the advisory team that helped establish the PCF 20 years ago and it has been fun to watch how the PCF has grown and evolved over the years to meet the changing demands of compliance professionals. By connecting compliance professionals, regulators, advisors and thought leaders, PCF didn't just set the bar, it created the bar that many other organizations have tried to emulate. Having been part of the PCF, first as an advisor and now a Global Chief Compliance Officer, I can confidently say that the PCF has been the one constant that compliance professionals can rely on for current thought leadership, industry networking and sharing of better practices. I am excited to see how the next generation of compliance leaders further shape and influence this important dialogue about compliance and risk."

Jonathon Kellerman, EVP, Global Chief Compliance Officer, Allergan

WASHINGTON, DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- SEPTEMBER 25, 2019: The 20th Anniversary Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, will be held November 6 - 8, 2019 at the Mandarin Oriental in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).

(Jointly Sponsored by PCF and PhRMA; Special November 6
Morning Session, Invitation-only)

Sally Molloy, JD
Acting Chief, Strategy, Policy & Training Unit, Fraud Section, Former Assistant U.S. Attorney, US Attorney's Office, Northern District of Georgia, US Department of Justice, Washington, DC


Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD

Brian Allen Benczkowski, JD
Assistant Attorney General, Criminal Division, US Department of Justice; Former Principal Deputy Assistant Attorney General for Legislative Affairs; Former Republican Staff Director, Committee on the Judiciary, US Senate; Former Staff, Senator Pete Domenici and Representative Jim Sensenbrenner, Washington, DC

Alexandra Christina, Countess of Frederiksborg
Member, Board of Directors - Chairperson Ethics and Compliance Board Committee, Ferring Pharmaceuticals, Co-author, The Sincerity Edge, Former Poling Chair of Business and Government, Kelley School of Business, Indiana University, Copenhagen, Denmark

Susan Dentzer
Visiting Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC


Douglas M. Lankler, JD
Executive Vice President, General Counsel, Pfizer, Former Assistant US Attorney, Southern District of New York, US Department of Justice, New York, NY

Daniel Ronald Levinson, JD
Former Inspector General, US Department of Health and Human Services, Former Inspector General, US General Services Administration, Former Chairman, US Merit Systems Protection Board, Former General Counsel, US Consumer Product Safety Commission, Washington, DC

Lori Queisser
Senior Vice President and Global Chief Compliance Officer, Teva Pharmaceuticals; Former Sr. VP Global Compliance and Business Practices; Schering-Plough Corporation; Former Vice President, Chief Compliance Officer, Eli Lilly; Former Member, PCF Executive Committee, Horsham, PA

Arjun Rajaratnam, JD, MS
Chief Compliance Officer, Smith & Nephew; Former Compliance Officer, US Pharmaceuticals, GlaxoSmithKline; Former Member, PCF Executive Committee; Raleigh, NC

James Sheehan, JD
Chief, Charities Bureau at Attorney General of New York, Former Chief Integrity Officer, Executive Deputy Commissioner, City of New York Human Resources Administration, Former NY Medicaid Inspector General, Former Associate United States Attorney, US Attorney's Office for the Eastern District of Pennsylvania, New York, NY

Susan Winkler, JD
Partner, Pierce Bainbridge Beck Price & Hecht LLP, Former Assistant US Attorney and Head, Health Care Fraud Unit, US Attorney's Office for the District of Massachusetts, Boston, MA

Kris Curry, MBA
Principal, Assurance Services, EY, Former Vice President, Global Chief Compliance Officer, Pharma Sector, Johnson & Johnson, Philadelphia, PA (Moderator)


Charlene E. Davis, JD
Associate Vice President & Head of Healthcare Compliance North America, Sun Pharmaceutical Industries, Princeton, NJ

Adam Dubow, JD
Global Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Princeton, NJ

Keith Korenchuk, MPH, JD
VP and Chief Compliance Officer Danaher Diagnostics and Beckman Coulter Diagnostics, DANAHER Corporation; Former Partner, Arnold & Porter Kaye Scholer; Chevy Chase, MD

Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Sunitha Ramamurthy, JD
Head of Compliance, Loxo Oncology, wholly owned subsidiary of Eli Lilly; Former Executive Director, Office of Ethics and Compliance, Boehringer Ingelheim Pharmaceuticals; Stamford, CT

Thomas J. Schumacher, JD
Vice President and Global Chief, Ethics and Compliance Officer, Medtronic, Fridley, MN

Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA (Moderator)


Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission, Former Assistant U.S. Attorney, US Attorney's Office, Western District of Michigan, Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC

David Last, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY (Moderator)


John Claud, JD
Assistant Director, Consumer Protection Branch, US Department of Justice, Washington, DC

Rachael A. Honig, JD
First Assistant U.S. Attorney, U.S. Attorney's Office, District of New Jersey, US Department of Justice; Former Corporate Counsel, Litigation, Celgene; Newark, NJ

Amanda Masselam Strachan, JD
Assistant US Attorney and Chief, Health Care Fraud Unit, US Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC (Moderator)

(Industry-only session for pharma and medical device compliance professionals and in-house counsel only)

Jacob T. Elberg, JD
Associate Professor of Law, Seton Hall Law School, Former Chief, Health Care & Government Fraud Unit and Assistant US Attorney, US Attorney's Office, District of New Jersey, US Department of Justice, Newark, NJ

Hosted by the PCF and the PhRMA CCO Working Group
  • Risk Assessment Recommendations Based on DOJ Updated Guidance
  • Third Party Interactions, Including Distributors and Non-Distributor 3rd Party Vendor Compliance (begins at 10:00 am)
  • Investigations: Interconnectivity of Auditing, Monitoring, and Investigations, Including Privilege
  • Emerging Role of Analytics, Big Data & AI Opportunities for Life Sciences...
  • Welcome and Introduction: PCF Co-Chairs
  • 20th Anniversary Dialogue: Lessons Learned
  • Keynote: OIG Update
  • US DOJ Keynote
  • FDA Keynote
  • What Pharma/Medical Device Industries Can Learn from the Opioid Cases
  • Annual Chief Compliance Officer Roundtable
  • Compliance Considerations for Gene Therapy and Ultra Rare Disease Products
  • HCP Contracting--Benchmarking and Lessons Learned...
  • Navigating Drug Price Transparency Laws...
  • Setting your Five-Year Strategic Compliance Plan
  • Co-chair Welcome and Introductions
  • Keynote by Alexandra Christina, Countess of Frederiksborg
  • US DOJ and US SEC Update on FCPA Enforcement
  • AUSA Roundtable
  • Prosecuting Illegal Kickbacks: The Cost of Noncompliance
  • Reduce Compliance Risk Using a "Portfolio" Approach to Training! (Microlearning Alone is Not the Answer)
  • Compliance Considerations for Small to Mid-sized Organizations
  • Interactions with Patients Including Benchmarking on Patient Services Compliance
  • Enhanced Compliance Monitoring
  • Best Practices Calculating Profit Disgorgement in Preparation for Compliance Settlements
  • Annual Medical Device Roundtable
  • Lessons Learned from Enforcement Actions
  • Compliance Program Operations: Building Effective and Right Sized Compliance Programs
  • Value-Based Arrangements
  • Framework for Determining Fair Market Value (FMV)
  • Helping Patient Access to Products The Opioid Crisis: Compliance and Enforcement Trends
  • Issues with Medical Device/Combination Products
  • Charitable Contributions Compliance Considerations
  • How do you Modernize your Compliance Program to Prepare for the Future of Health?
  • Medical Affairs Proactive Communications, Engagement by Manufacturers
  • Transparency and HCP Engagement
  • Compliance -- Board Communications: Effective Measurement and Reporting Strategies
  • Best Practices when Transitioning from Healthcare Compliance Risk to Enterprise Risk Assessments
  • Medical Device Asset Management Risk Considerations
  • Responding to CCPA, GDPR and the Tumultuous World of Data Privacy
  • Social Media Engagement by Manufacturers
  • Conducting R&D Compliance Risk Assessments
  • Ensuring a Smooth Transition of Compliance Programs During Mergers & Acquisitions
  • Investigations: Properly Executing a Compliance Investigation Initiated by a Whistleblower
  • Interactions with Specialty Pharmacy
  • Practice Development Programs (e.g., Free or Discounted Marketing Services)
  • Developments in Pharmaceutical and Medical Device Pricing and Cost Containment...
  • The Changing Face of the Qui Tam
Featuring Jacob T. Elberg, JD


Meredith S. Auten, JD
Partner, Morgan Lewis, Co-chair, White Collar Committee Qui Tam Subcommittee, ABA Criminal Justice Section, Philadelphia, PA

Timothy Ayers, JD, MPH
Founder, Life Science Compliance Consulting, LLC, Former VP, Chief Compliance Officer, Horizon Pharma plc., Oklahoma City, OK

Yogesh Bahl, CPA, MBA
Managing Director, AlixPartners, New York, NY

Ann E. Beasley, JD
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA

Thomas Beimers, JD
Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, Former Special Assistant United States Attorney, US Attorney's Office, Eastern District of Michigan, Minneapolis, MN and Washington, DC

Ela Bochenek, JD
Vice President and Chief Compliance Officer, Nabriva Therapeutics PLC, Former Assistant Dean Graduate & Professional Education, Seton Hall University School of Law, King of Prussia, PA

Kathleen M. Boozang, JD, LLM
Dean and Professor of Law, Seton Hall University School of Law, Newark, NJ

Bernadette M. Broccolo, JD
Partner, McDermott Will & Emery LLP, Chicago, IL

Carla Brooks, MS
Senior Director, Compliance Monitoring, Auditing & Investigations, United Therapeutics, Former US Compliance Director, Market Access & Government Affairs, AstraZeneca, Silver Spring, MD

Christie Camelio
Vice President, Deputy Global Chief Compliance Officer, Celgene, Former Executive Director, Head of Risk Management Center of Excellence, Novartis Pharmaceuticals, Florham Park, NJ

Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D IA, FMV, Sanofi Genzyme, Jamaica Plain, MA

Jennifer Chillas, JD
Senior Corporate Counsel, Bristol-Myers Squibb, New York, NY

Michael R. Clarke, CCEP, JD
Vice President, Global Chief Compliance Officer, ConvaTec, Former Vice President, Corporate Compliance, Indivior, Inc., Bridgewater, NJ

Brian Conner
Chief Compliance Officer, Strongbridge Biopharma plc, Former Assistant Compliance Officer of the Americas, Shire, Feasterville Trevose, PA

Thomas Costa, JD
Member, US Board of Directors, Sanofi, Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC

Jared D. Crafton
Principal, Assurance Services, Forensic & Integrity Services, EY, Boston, MA

Tiffany Cummings-Damiani, MBA
Vice President, Corporate and Healthcare Compliance, Global Compliance, Insmed, Former Senior Director, Global Compliance, Teva, Philadelphia, PA

Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL

BJ D'Avella, MBA
Senior Manager, Deloitte Advisory, Deloitte & Touche LLP, New York, NY

Danielle Davis, LLB
Director, Compliance Counsel, Heron Therapeutics, Inc; Former Senior Director Compliance, Sentynl Therapeutics; Phoenix, AZ

CJ DeKreek, CFA
Senior Director, Ankura, Atlanta, GA

Julie DeLong, CFA
Senior Managing Director, Ankura Consulting Group, LLC, Atlanta, GA

Gary Del Vecchio
Health Care Compliance Officer Cardiovascular & Metabolism and Puerto Rico, Janssen; Former Executive Director, US Pharmaceutical Compliance and Ethics, BMS, Pennington, NJ

NoŽl (Giglio) Denice, JD
Legal Counsel, Legal Compliance, Philips North America, LLC, Andover, MA

Mark A. DeWyngaert, PhD.
Managing Director, Deloitte Advisory, Deloitte & Touche LLP, Stamford, CT

Sarah diFrancesca, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY

Christian A. Dingler
Associate Director, Navigant, Life Sciences, Richmond, VA

Stefanie A. Doebler, JD
Of Counsel, Covington & Burling LLP, Washington, DC

Gildas Durand
Principal, Forensic & Integrity Services, EY, Miami, FL

Eileen Erdos
Principal, Forensic & Integrity Services, EY, Chicago, IL

Alison Fethke, JD
Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL

Kellie Fidler, MBA, PMP
Director, Global Compliance Risk Mitigation & Monitoring Strategy, Bristol-Myers Squibb, Princeton, NJ

Elaina Filauro
Senior Manager, Deloitte Advisory, Deloitte & Touche LLP, New York, NY

Christine Fiore, MBA
Executive Director, Ethics and Commercial Compliance, Boehringer Ingelheim, Former Group Director Ethics and Compliance, Smith & Nephew, Ridgefield, CT

Jeffrey (Jeff) Fleming, JD
Assistant General Counsel, Pharma R&D, GlaxoSmithKline, Philadelphia, PA

Maya P. Florence, JD
Partner, Health Care and Life Sciences, Skadden Arps LLP, Boston, MA

Sarah A. Franklin, JD
Partner, and Vice-chair, Life Sciences Litigation and Investigations, Covington & Burling LLP, Former Attorney, Bureau of Consumer Protection, FTC, Washington, DC

Nereyda Garcia, JD
Global Heath, Ethics and Compliance, Alnylam Pharmaceuticals, Former Sr. Director, Compliance, Biogen Idec, Cambridge, MA

Deeona R. Gaskin, MPH, JD
Associate, Sidley Austin LLP, Former Associate Chief Council, FDA, Washington, DC

Virginia "Ginny" A. Gibson, JD
Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA

Thomas M. Glavin, JD
Chief Compliance Officer for the Americas, Olympus Corporation of the Americas; Former Vice President, US/Americas Compliance Officer, Shire, Center Valley, PA

Jonathan Glazier, MBA, JD
Head of Legal Compliance, Philips North America, Former Sr Director of Corporate Compliance and Privacy Officer, Fresenius Medical Care North America, Andover, MA

Kimberly J. Gold, JD, CIPP/US
Partner, Life Sciences Health Industry and Data Privacy Groups, Reed Smith, New York, NY

Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY

Christine Gordon, JD
Deputy Chief Compliance Officer, Olympus Corporation of the Americas; Director, Board of Directors, ESSA Bancorp, Inc; Former Assistant District Attorney, Office of the District Attorney, City of Philadelphia, Bethlehem, PA

Kimi Gorman, CCEP, CFE
Sr. Director, Ethics & Compliance - Operations & Government Accountability, Monitoring & Auditing, Novo Nordisk Inc.; Former Compliance Manager, B. Braun Medical; Princeton, NJ

Adam Greene, JD, MPH
Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP, Former Senior Health Information Technology and Privacy Specialist, Office for Civil Rights, HHS, Washington, DC

Nancy Grygiel, JD
Vice President, Worldwide Compliance & Business Ethics, Amgen, Newbury Park, CA

Christine Handel, JD
Vice President, Global Compliance Operations, Walgreens Boots Alliance, Deerfield, IL

Michael G. Hercz, JD
Senior Vice President & General Counsel, Sentynl Therapeutics, Inc., Solana Beach, CA

Casey J. Horton, CFE
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL

William Hrubes, MS
Vice President and Chief Compliance Officer, ACell, Inc. Former Healthcare Compliance Officer, DePuy Orthopaedics, Columbia, MD

Pearl Hsieh, JD
Senior Counsel, US Commercial, Group Counsel, Smith & Nephew, Columbia, MD

Franziska Janorschke
Global Head, Business Practices Office, Novartis International AG, Basel Area, Switzerland

Karen Johnson, MBA
Executive Director, Compliance and Ethics, Corporate Ombudsman, Bristol-Myers Squibb, Princeton Pike, NJ

Darren R. Jones, CIA
Senior Principal, Commercial Compliance, Global Consulting Practice Leader, IQVIA, New York, NY

Shannon Kelley, JD
Vice President, Head of North America Compliance, Sanofi, Former Assistant US Attorney and Deputy Chief of Litigation, Boston US Attorney's Office, US Department of Justice, Cambridge, MA

Elizabeth "Beth" Kolbe, JD
Associate, Sidley Austin LLP, Washington, DC

Joanne Kwan, JD, PhD
Corporate Counsel, Commercial, Exelixis, San Francisco, CA

Cheryl Lee, MBA
Executive Director, Worldwide Markets, Healthcare Compliance, Celgene, Former Sr. Manager Compliance, Worldwide BioPharmaceutical Business, Pfizer, Summit, NJ

Puja Leekha, JD
Vice President, Chief Compliance Officer, Corporate Compliance, Lundbeck Pharmaceuticals; Former Division Legal Counsel & Compliance Officer, Stryker Corporation; Deerfield, IL

Richard Liner, JD, MPH
Senior Counsel, Compliance & Investigations, Bayer Healthcare, Whippany, NJ

Mark Linver, MS
Managing Director, Deloitte & Touche LLP, Stamford, CT

Carrie Sarhangi Love, JD
Litigation Partner, Armstrong Teasdale LLP; Former Assistant District Attorney, Philadelphia; Philadelphia, PA

Ali Lyons
Senior Director, Ethics & Compliance, Aegerion Pharmaceuticals, a Novelion Therapeutics Company, Former Operations Lead, Ethics and Compliance, Eli Lilly and Company, Cambridge, MA

Jill Fallows Macaluso, JD, RN
Corporate Vice President, Chief Ethics & Compliance Officer, Novo Nordisk Inc., Princeton, NJ

Anna L. Mack
Senior Manager, Global Compliance, Danaher Diagnostics and Beckman Coulter Diagnostics, Former Senior Manager, Compliance, Allergan, Orange County, CA

Susan Markel
Managing Director, AlixPartners, Former Chief Accountant, Division of Enforcement, US Securities and Exchange Commission, Washington DC

Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Ridgefield, C

Heather McCollum, JD, MHA, CCEP-I
Director Compliance, Shionogi Inc., Florham Park, NJ

William A. McConagha, JD
Partner, Sidley Austin, LLP, Former Health Policy Advisor, Health, Education, Labor and Pensions Committee, US Senate, Former Assistant Commissioner, FDA, Washington, DC

Jean McKiernan, MBA
Managing Director, Dovetail Consulting Group, LLC, Chicago, IL

Jenny McVey, PhD
Compliance Risk & Mitigation, Novo Nordisk, Inc., Former Compliance Officer, Hands International, Princeton, NJ

Vahan Minassian, JD
Director, US Promotional Monitoring Lead, Pfizer, Philadelphia, PA

Gregory S. Moss, JD
Executive Vice President, General Counsel and Corporate Secretary, Chief Compliance Officer, Kadmon Holdings, Inc., New York, NY

Brad Mroski, CPA, CFE
Managing Director, AlixPartners; Former Assistant Chief Accountant, Division of Enforcement, U.S. Securities & Exchange Committee Enforcement; Dallas, TX

Kamleh J. Nicola, LLB
Partner, Baker & McKenzie LLP, Toronto, Canada

Katherine Norris, MPA
Director, Corporate Compliance & Risk Management, Berkeley Research Group LLC, Washington, DC

Dan O'Connor
Senior Vice President, PharmaCertify, a Division of NXLevel Solutions, New York, NY

Michael O'Connor
Vice President of Compliance Technology, Porzio Life Sciences, LLC, Former Global Head Compliance and Ethics Operations, Alexion, Former Executive Director, Global Head, IS Business Consulting, Boehringer Ingelheim, New York, NY

Josh Tomas O'Harra, MS, JD
Assistant General Counsel, Eli Lilly and Company, Washington, DC

Casper Partovi, MA, JD
Vice President, Law, Amgen, Los Angeles, CA

Gregory Paw, JD
Partner, Freeh, Sporkin & Sullivan, Former Director, New Jersey Division of Criminal Justice, Former Assistant US Attorney, US Attorney's Office, Eastern District of Pennsylvania, New York, NY

Amy Pawloski, CPA, PMP, CCEP
Compliance Officer-Operations, Endo Pharmaceuticals; Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA

Kelliann H. Payne, JD
Partner, Hogan Lovells LLP, Former Assistant General Counsel at QVC, Inc., Philadelphia, PA

Patrick Phelan, JD
Partner, Covington & Burling LLP, Washington, DC

Erica Powers
Director, Compliance Operations, Sage Therapeutics, Former Director Corporate Compliance, Vertex, Cambridge, MA

Kristin Rand, JD, MA
Vice President and Compliance Officer, Seattle Genetics, Former Compliance Director, Policy, Ethics, Training & Communication, Genentech, New York, NY

Marc Stephen Raspanti, JD
Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP, Co-chair, White Collar Committee Qui Tam Subcommittee, ABA Criminal Justice Section, Philadelphia, PA

Kelly N. "Nikki" Reeves, MPA, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding LLP, Washington, DC

Lesley C. Reynolds, JD
Partner, Life Sciences Health Industry Group, Reed Smith, Washington, DC

Chapman Richardson
Global Head, Data Consumerization, Sanofi; Former Global Head Next Generation Digital, Novartis; Bridgewater, NJ

John C. Richter, JD
Partner, King & Spalding, Former Acting Assistant Attorney General, Criminal Division , US Department of Justice, Former US Attorney, Western District of Oklahoma, Washington, DC

Ashley Riley, JD
Senior Manager Deloitte Advisory, Deloitte & Touche LLP, Charlotte, NC

Tim Robinson, JD
Chief Legal and Privacy Officer, MediSpend, Portsmouth, NH

Angela Rodin, MBA
Principal, KPMG, Former Vice President, Global Head of Investigations and Monitoring, GlaxoSmithKline Pharma GmbH, Washington, DC

Oscar Rodriguez
Chief Architect, BlackThorn Therapeutics; Co-chair, Technology and Standards Subcommittee, The Alliance for Artificial Intelligence in Healthcare (AAIH), New York, NY

Mark Scallon, MHA
Senior Principal, IQVIA Global Compliance, Richmond, VA

Katie Schottmiller, MS, CPA
Director, North America Independent Business Monitoring, GSK, Raleigh-Durham, NC

Jessica C. Sergi, JD
Senior Legal Counsel, Neurology & Immunology, EMD Serono, Rockland, MA

Laura Skinner, MBA
Senior Manager, Deloitte Advisory, Deloitte & Touche LLP, Austin, TX

Jack Tanselle, MBA
Managing Director, Deloitte & Touche LLP, Indianapolis, IN

Meredith Taylor, JD
Vice President Compliance and Privacy, Novocure, Malvern, Pennsylvania

Ann-Marie Tejcek, MA
Senior Director North American Ethics & Compliance Officer, Eli Lilly and Company, Indianapolis, IN

Bryan Timer, MS
Director, Data Analytics & Transparency, Merck & Co., Inc., Kenilworth, NJ

Nancy S. Travis, MS
Vice President, International Compliance and Governance, Advanced Medical Technology Association (AdvaMed), Washington, DC

Jonathan Turner, MSc
Vice President, Global Compliance Leader, Smith & Nephew; Adjunct Faculty, Florida State University and University of Memphis; Association of Certified Fraud Examiners, Memphis, TN

Manny Tzavlakis
Managing Partner, Helio Health, Morristown, NJ

Sarah Venable, JD, MS
Risk Analytics Manager, Independent Business Manager, GlaxoSmithKline, Raleigh, NC

Rena Verma, MBA
Senior Managing Director, Information Governance, Privacy and Security Practice, FTI Consulting, New York, NY

Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS; Washington, DC

Richard H. Walker, JD
Partner, King & Spalding; Former Director of Enforcement, US Securities and Exchange Commission; New York, NY

Beth Weinman, JD
Counsel at Ropes & Gray LLP; Former Associate Chief Counsel, FDA; Washington, DC

Elizabeth Weiss, JD
Chief Compliance Counsel for Patient Support Services and Payer Access, Pfizer, Peapack, NJ

Caroline West, JD
Global Chief Compliance Officer, Olympus Corporation, Former Sr. VP , Chief Compliance and Risk Officer, Shire, Former VP Global Legal Compliance, Aventis, Philadelphia, PA

Christopher L. White, JD
Chief Operating Officer and General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC

Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC; Editor, Life Science Compliance Update; Senior Fellow & Adjunct Professor, Life Sciences Compliance at Mitchell Hamline School of Law, West Chester, PA

Jonathan Wilkenfeld, MBA
Partner, Potomac River Partners, Washington, DC

Catherine Williams, JD
Director - Privacy Office, Novo Nordisk, Former Assistant General Counsel, Privacy & K-12, Corrections & Leisure, Aramark, Plainsboro, NJ

Susan Williamson, MBA, CPA
Senior Vice President & Chief Compliance Officer, Endo Pharmaceuticals, Philadelphia, PA

Heather Young, JD
Senior Manager, Compliance Business Partner, Olympus Corporation of the Americas; Former Assistant District Attorney, Office of the District Attorney, City of Philadelphia, Philadelphia, PA

Mark Zaleski, MBA
Director Legal Compliance, Philips; Former Senior Finance Manager, Intel Corporation, Boston, MA


A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November 6 - 8, 2019
Mandarin Oriental, Washington, DC
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
April 20 - 22, 2020
Sheraton Munich Arabellapark Hotel
Munich, Germany
www.International PharmaCongress.com


The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 70+ distinguished researched-based pharmaceutical manufacturers and biotech companies. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effect corporate compliance programs.


Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ (PCF Secretary)

Jeffrey Kawalek, MBA
Deputy Chief Compliance Officer, Jazz Pharmaceuticals, Inc., Philadelphia, PA (PCF Chair)

Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD (PCF Treasurer)

Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US, Bridgewater, NJ (PCF Co-chair)

Donna White, CCEP
Vice President, Contracts & Compliance, Chiesi, USA, Cary, NC (PCF Co-chair)

Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals, Parsippany, NJ (PCF Co-chair)




Sponsor of Pharma Congress

Sponsor of Pharma Congress

Sponsor of Pharma Congress

Sponsor of Pharma Congress



Accounting Professionals: Approved for up to 19.0 NASBA CPE Credits for onsite attendance only.

Compliance Professionals: Pending approval to offer Compliance Certification Board (CCB)® credits.

Attorneys: Pending approval to offer Pennsylvania MCLE credits.

Click here for more information.

The Pharma Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of local, state and federal government, consumer advocate organizations, safety net providers, academics, students and health services research organizations.

Click here for more information.

Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction

Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office


Click here for a sample stream


Tweet using #PharmaCongress


2007 - Brussels

2008 - Paris

2009 - Rome

2010 - Berlin

2011 - Istanbul

2011 - Singapore

2012 - Budapest

2012 - Shanghai

2012 - S„o Paulo

2013 - Madrid

2013 - Kuala Lumpur

2014 - Dubai

2014 - Mexico City

2014 - Shanghai

2015 - Manila

2016 - Warsaw

2017 - Lisbon

2018 - Vienna

2019 - Athens

For Congress registration information, visit https://www.pharmacongress.com/registration/, email registration@hcconferences.com, or call 800-503-7419.

For sponsorship and exhibit information visit https://www.pharmacongress.com/promotional-opportunities/, or contact Justin Sorensen, Exhibit Manager, 206-452-0609 phone, 206-319-5303 fax, exhibits@hcconferences.com.